Valence ロゴ
人気
ログイン
Loading data for NEUP — first visit, this takes a few seconds.

ウォッチリストに追加

Neuphoria Therapeutics In...

NasdaqGM: NEUP · リアルタイム株価 · USD
3.91
-0.04 (-1.01%)
終値時点： Aug 21, 2026, 8:00 PM
3.94
+0.77%
時間外: 7:30 PM

株価、主要な数字、最新ニュースをひとまとめにしたページです。

Neuphoria Therapeutics Inc.（NEUP）の株価・分析・データ

-1.01%

データがありません

買気配3.89
時価総額21.13M
売上高（TTM）-13.27K
純利益（TTM）-17.43M
n/a
-7.82
n/a
-1.61
PBR（TTM）0.71
PSR（TTM）-1592.81
決算発表日n/a
売気配3.96
出来高179,695
平均出来高（20日）200,538
始値3.98
前日終値3.95
当日レンジ3.91 - 4.05
52週レンジ3.19 - 21.40
アナリストn/a
目標株価n/a
配当n/a
権利落ち日n/a

NEUPについて

Neuphoria Therapeutics Inc., a clinical stage biopharmaceutical company, discovers and develops novel allosteric ion channel modulators for the treatment of central nervous system disorders in Australia. Its lead product candidate includes BNC210, a selective negative allosteric modulator of the a7 for the treatment of social anxiety disorder; and is phase 2b to treat post-traumatic stress disorder. The company also develops BNC101, a monoclonal ...

[続きを読む]
業種 Biotechnology
セクター Healthcare
IPO日 Dec 16, 2021
従業員数 7
上場取引所 NasdaqGM
ティッカー NEUP
ウェブサイト https://www.neuphoriatx.com
企業情報の全文

業績

2024年のNeuphoria Therapeuticsの売上高は0で、前年の0からundefined%の増加でした。 利益は-15.49Mで、-27.54%の減少でした。

財務諸表

決算サプライズ

Neuphoria TherapeuticsはMay 15, 2026に四半期決算を発表しました：
  • 売上高は $0 で、予想を下回りました $0, うち -100.00% の前年比減少.
  • EPSは -0.09 で、予想を上回りました 0.47, うち -101.37% の前年比減少.
news image

4週間前 · Proactive

Scancell sees high demand in retail share offer, seals £15.7m from UK investors

Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP) confirmed the UK leg of its equity funding has raised gross proceeds of £15.7 million after strong retail demand prompted the cancer immunotherapy ...

news image

1か月前 · Proactive

SMALL-CAP MOVERS: Nasdaq-bound Scancell catches the eye as AIM's headcount falls to 612

Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP) saw its shares drop 27% this week, but the movement obscures the real story, which is a largely positive one for investors. It may take the market ...

news image

1か月前 · MT Newswires

Neuphoria Therapeutics Agrees to All-Share Takeover by Scancell

Neuphoria Therapeutics (NEUP) and Scancell Holdings said Thursday they have agreed to an all-stock m

news image

1か月前 · Proactive

Scancell to join Nasdaq through Neuphoria merger and $89 million funding package

Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP), the Oxford-based cancer immunotherapy developer listed on London's junior AIM market, has agreed an all-share merger with US biotech Neuphoria The...

news image

1か月前 · Stocktwits

MRK, NEUP Stocks Drop As Merck Scraps Another Alzheimer’s Drug Trial Under Neuphoria Partnership

Merck cited business reasons for the discontinuation of the investigational drug.

2ページ中1ページ